"Filiform" serrated adenomas: A clinicopathologic and immunophenotypic study of 18 cases

American Journal of Surgical Pathology

Volumn 31, Issue 8, 2007, Pages 1238-1245

  Yantiss, Rhonda K ^a   Oh, Kirstine Y ^b   Chen, Yao Tseng ^a   Redston, Mark ^b   Odze, Robert D ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adenoma; BRAF; Hyperplastic polyp; K ras; MGMT; Microsatellite instability; p53; Sessile serrated adenoma; Sessile serrated polyp

Indexed keywords

6 O METHYLGUANINE; B RAF KINASE; BETA CATENIN; K RAS PROTEIN; KI 67 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; PARAFFIN; PROTEIN MLH1; PROTEIN MSH2; PROTEIN P53; TRANSCRIPTION FACTOR CDX2;

ADULT; AGED; ARTICLE; CHROMOSOME 1P; CLINICAL ARTICLE; CLINICAL FEATURE; COLON; COLON POLYPOSIS; COLORECTAL ADENOMA; CONTROL GROUP; CONTROLLED STUDY; DNA EXTRACTION; DYSPLASIA; FEMALE; HETEROZYGOSITY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; MICROSATELLITE INSTABILITY; PATHOLOGY; POLYMERASE CHAIN REACTION; POLYP; POLYPECTOMY; RECTUM;

ADENOMATOUS POLYPS; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; EPITHELIAL CELLS; FEMALE; GENES, P53; GENES, RAS; GENETIC MARKERS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; PROTO-ONCOGENE PROTEINS B-RAF; TUMOR MARKERS, BIOLOGICAL;

EID: 34547630471     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31802d74c0     Document Type: Article

References (24)

1. Abraham SC, Burgart LJ, Odze RD. Polyps of the large intestine. In: Odze RD, Goldblum JR, Crawford JM, eds. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. Philadelphia: Saunders; 2004:354-355.
2. Beach R, Chan AO, Wu TT, et al. BRAF mutations in aberrant crypt foci and hyperplastic polyposis. Am J Pathol. 2005;166:1069-1075.
3. Cooper HS. Benign epithelial polyps of the intestines. In: Ming SCAG, Baltimore H, eds. Pathology of the Gastrointestinal Tract. Baltimore: Williams & Wilkins; 1998:823-825.
4. Fogt F, Brien T, Brown CA, et al. Genetic alterations in serrated adenomas: comparison to conventional adenomas and hyperplastic polyps. Hum Pathol. 2002;33:87-91.
5. Goldman H, Ming S, Hickock DF. Nature and significance of hyperplastic polyps of the human colon. Arch Pathol. 1970;89:349-354.
6. Hiyama T, Yokozaki H, Shimamoto F, et al. Frequent p53 gene mutations in serrated adenomas of the colorectum. J Pathol. 1998;186:131-139.
7. Iino H, Jass JR, Simms LA, et al. DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer? J Clin Pathol. 1999;52:5-9.
8. Jass JR, Cottier DS, Pokos V, et al. Mixed epithelial polyps in association with hereditary non-polyposis colorectal cancer providing an alternative pathway of cancer histogenesis. Pathology. 1997;29:28-33.
9. Jass JR, Baker K, Zlobec I, et al. Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer. Histopathology. 2006;49:121-131.
10. Konishi K, Yamochi T, Makino R, et al. Molecular differences between sporadic serrated and conventional colorectal adenomas. Clin Cancer Res. 2004;10:3082-3090.
11. Leach FS, Nicolaides NC, Papadopoulos N, et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell. 1993;75:1215-1225.
12. Lee EJ, Choi C, Park CK, et al. Tracing origin of serrated adenomas with BRAF and KRAS mutations. Virchows Arch. 2005;447:597-602.
13. Leggett BA, Devereaux B, Biden K, et al. Hyperplastic polyposis: association with colorectal cancer. Am J Surg Pathol. 2001;25:177-184.
14. Longacre TA, Fenoglio-Preiser CM. Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol. 1990;14:524-537.
15. McBain AJ, Macfarlane GT. Ecological and physiological studies on large intestinal bacteria in relation to production of hydrolytic and reductive enzymes involved in formation of genotoxic metabolites. J Med Microbiol. 1998;47:407-416.
16. Oberschmid BI, Dietmaier W, Hartmann A, et al. Distinct secreted Frizzled receptor protein 1 staining pattern in patients with hyperplastic polyposis coli syndrome. Arch Pathol Lab Med. 2004;128:967-973.
17. Oh K, Redston M, Odze RD. Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplasticadenoma-carcinoma (serrated) carcinogenic pathway in the colon. Hum Pathol. 2005;36:101-111.
18. Peralta RC, Casson AG, Wang RN, et al. Distinct regions of frequent loss of heterozygosity of chromosome 5p and 5q in human esophageal cancer. Int J Cancer. 1998;78:600-605.
19. Sawyer EJ, Cerar A, Hanby AM, et al. Molecular characteristics of serrated adenomas of the colorectum. Gut. 2002;51:200-206.
20. Snover DC, Jass JR, Fenoglio-Preiser C, et al. Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol. 2005;124:380-391.
21. Torlakovic E, Snover DC. Serrated adenomatous polyposis in humans. Gastroenterology. 1996;110:748-755.
22. Torlakovic E, Skovlund E, Snover DC, et al. Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol. 2003;27:65-81.
23. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96:261-268.
24. Yang S, Farraye FA, Mack C, et al. BRAF and KRAS mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. Am J Surg Pathol. 2004;28:1452-1459.